COPD pragmatic randomised clinical trial
Research payments
$1,421,565
Through program year 2021, $1,421,565 in research payments was reported against COPD pragmatic randomised clinical trial, across 329 payments, paid by Boehringer Ingelheim Pharmaceuticals, Inc..
- Paid by
- Boehringer Ingelheim Pharmaceuticals, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $460,987 | 74 |
| 2020 | Research | $97,055 | 80 |
| 2019 | Research | $863,524 | 175 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Catherine Laruffa Blanchester, OH Named on 5 payments
- Hicham Siouty Torrance, CA Named on 5 payments
- Joseph Labuda Uniontown, PA Named on 5 payments
- Francis Averill Clearwater, FL Named on 5 payments
- Bradley Block Oviedo, FL Named on 5 payments
- Tiffany Pluto Scottdale, PA Named on 5 payments
- David Maybee New Bern, NC Named on 5 payments
- Timothy Liesching Burlington, MA Named on 5 payments
- Randall Richwine Fort Worth, TX Named on 5 payments
- Salma Saiger Mesquite, TX Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.